Standout Papers

Targeting proprotein convertase subt... 2020 2026 2022 2024314
  1. Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside (2024)
    Xuhui Bao, Yongjun Liang et al. Signal Transduction and Targeted Therapy
  2. Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer (2020)
    Xinjian Liu, Xuhui Bao et al. Nature

Immediate Impact

2 from Science/Nature 60 standout
Sub-graph 1 of 23

Citing Papers

FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024 Standout
In-situ-sprayed therapeutic hydrogel for oxygen-actuated Janus regulation of postsurgical tumor recurrence/metastasis and wound healing
2024 Standout
2 intermediate papers

Works of Liyi Xie being referenced

Second malignancy in young early-stage breast cancer patients with modern radiotherapy
2018
Challenges scoring radiation pneumonitis in patients irradiated for lung cancer
2012
and 1 more

Author Peers

Author Last Decade Papers Cites
Liyi Xie 327 215 96 265 230 54 1.0k
Marine Lefèvre 300 405 121 206 281 65 1.0k
Jiandong Zhang 417 330 60 233 251 78 1.0k
Ming Jin 621 214 71 339 432 77 1.4k
Feng Zhan 414 271 47 207 305 65 970
Hyunee Yim 257 170 62 126 155 64 1.1k
Sha Fu 444 258 90 257 355 76 1.1k
Marisa Cañadas‐Garre 427 169 73 189 249 52 1.0k
Masaharu Nishikido 331 390 50 136 258 58 982
Jessica Schmitz 449 288 195 272 129 63 1.3k
Tatsuo Morita 320 334 95 121 380 98 1.0k

All Works

Loading papers...

Rankless by CCL
2026